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Ernst Cancrinus, MD,e Frans A. M. Brooijmans, MSc,f Kenneth Meijer, PhD,g and Joep A. W. Teijink, MD, PhD,a,b
Eindhoven, Maastricht, Veldhoven, and Geldrop, The NetherlandsABSTRACT
Background: Patients with intermittent claudication (IC) tend to walk slower and consume approximately 40% more
oxygen during walking compared with healthy individuals. An unfavorable locomotion pattern has been suggested to
explain this metabolic inefficiency. However, detailed knowledge of gait parameters in IC is lacking.
Methods: In a cross-sectional study, the gait pattern of newly diagnosed IC patients was compared with that of healthy
controls. Spatiotemporal gait parameters such as step length and duration of stance phase were obtained by a pho-
toelectric technique (OptoGait; Microgate, Bolzano, Italy). This system was previously found to have favorable concurrent
validity and test-retest reliability characteristics. Parameters were determined during pain-free and painful treadmill
walking at a comfortable self-determined walking pace. Each parameter was averaged on the basis of 80 steps.
Results: A total of 28 patients and 28 controls were examined. IC patients walked 1.2 km/h (27%) slower than controls
(P < .001), coinciding with a significantly shorter step length (20%) and lower cadence (11%). IC patients demonstrated
a longer stance and double support phase, even before the onset of ischemic pain. Differences were also observed in
segments of the stance phase, as a 14% shorter propulsion (P < .001) and 17% longer flat foot phase (P < .001) during
painful walking were found. In considering the absolute duration of these stance phase segments, differences were
found only for the flat foot time (D0.10 second; P < .001).
Conclusions: Patients with IC demonstrate an altered gait pattern compared with healthy controls. The most prominent
differences were a prolonged relative and absolute duration of the flat foot position during the stance phase. This
adaptation may be intuitive as an augmented arterial blood flow into skeletal muscles is allowed during a prolonged
relaxation phase. Therefore, not only the lack of propulsion but also a gain of relaxation may explain these gait
alterations. (J Vasc Surg 2017;66:515-22.)The most common symptom of peripheral arterial dis-
ease (PAD) is intermittent claudication (IC), character-
ized by limb pain that is elicited by exercise and
resolves after rest. Patients with IC demonstrate a limited
walking distance, lower physical activity levels, dimin-
ished isokinetic distal muscle strength, and reduced
quality of life.1-4
Patients with IC were found to consume more oxygen
during walking compared with healthy controls.5-7
Researchers have suggested various mechanisms
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x.doi.org/10.1016/j.jvs.2017.02.033requirement. For instance, an unfavorable gait pattern
and a reduced recovery of potential energy through
the pendulum-like mechanism were implicated.8 Inter-
estingly, some previous research excluded a reduced
metabolic efficiency, whereas others reported on mito-
chondrial respiratory defects in PAD.5,9
Previous studies found that IC patients walk slower and
have lower cadence rates and smaller stride lengths,
mainly caused by an increased double limb support and
stride time.1,10 However, only basic spatiotemporal param-
eters have been evaluated in IC to date. Studying distinct
subphases during the stance phase may also be inter-
esting, particularly foot contact and toe-off (propulsion).5,11
Calf muscles are known to contribute most to these sub-
phases of the stance phase, and precisely the calves are
considered the “functional end organs” in the lower ex-
tremity ischemia of IC patients.12,13 Besides, calf muscle
weakness has previously been described as a potential
mechanism underlying IC gait adaptions.14 Remarkably, a
recent study did not demonstrate altered duration of calf
muscle activation duringwalking in IC patients compared
with healthy controls.13 Nevertheless, spatiotemporal dif-
ferences at this level are likely and may provide further
insight into altered gait patterns. Further understanding
might contribute to the development of rehabilitation
strategies to restore the gait pattern and eventually
walking distances, quality of life, and possibly even survival515
ARTICLE HIGHLIGHTS
d Type of Research: Cross-sectional prospective non-
randomized controlled study
d Take Home Message: The 28 patients with claudica-
tion had a prolonged flat foot position during
walking that was evident before onset of pain. This
was significantly different from findings in 28 healthy
controls.
d Recommendation: The authors suggest that
changes in gait may be a compensatory mechanism
that enhances arterial blood flow in patients with
claudication.
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August 2017if one considers that reduced exercise capacity is themost
powerful harbinger of long-termmortality in PAD.15
One study on potential beneficial effects of supervised
exercise therapy (SET) failed to demonstrate any
improvement in altered gait pattern.16 However,
consensus on which type of exercise leads to optimally
improved walking ability is lacking.17 As a consequence,
current exercise protocols may not be tailored to confer
significant improvements in walking patterns. Moreover,
gait pattern outcomes may have been assessed inade-
quately, as previous research was mainly based on
limited number of steps.1,18 Fortunately, sensitive gait
analysis systems have become available, allowing cap-
ture of continuous data during treadmill walking. These
novel tools may optimize accuracy and generalizability
of collected data on the gait pattern.
The primary aim of this study was to explore spatiotem-
poral gait parameters during continuous treadmill
walking in IC patients and healthy controls. We hypothe-
sized that patients with IC possibly demonstrate alter-
ations of certain subphases of the stance phase.
METHODS
Participants. Patients were recruited from a population
presenting with new-onset manifestations of IC at
vascular surgery outpatient departments of three
regional Dutch hospitals (Catharina Hospital, Eindhoven;
Maxima Medical Center, Veldhoven; and St. Anna Hos-
pital, Geldrop). According to standardized institutional
protocols, potential patients underwent history taking
and a physical examination including an ankle-brachial
index (ABI) measurement during rest and after exercise.
Individuals demonstrating typical symptoms of claudi-
cation in at least one lower leg and a <0.90 resting ABI or
a >0.15 ABI drop after treadmill testing were eligible for
study.19 Inclusion criteria were >4 weeks of symptoms
and the ability to walk without typical IC pain for
$1 minute. Patients were excluded if they suffered from a
comorbid condition possibly influencing gait pattern,
such as lower extremity amputation, severe osteoarthritis
(based on the American College of Rheumatology oste-
oarthritis criteria20), previous knee or hip prosthesis, se-
vere cardiopulmonary problems (ie, Global Initiative for
Chronic Obstructive Lung Disease stage $III or New York
Heart Association class $III), neurologic diseases
including peripheral polyneuropathy (eg, due to diabetes
mellitus), Parkinson disease, stroke, previous surgery of
lower extremities, use of walking aids or orthopedic
shoes, or medication influencing walking pattern (eg,
psychotropic medication). Patients who experienced rest
pain, who suffered from chronic wounds, or who
received more than five sessions of SET during the pre-
ceding 3 years were also excluded.
Control subjects of similar age, gender, height, and
weight were recruited from family, friends, and hospital
personnel. They all exhibited a >0.90 rest ABI and didnot experience pain or limitations during walking.
Exclusion criteria were as reported. Participants who
were willing to undergo the study protocol were coun-
seled before providing written informed consent. All
procedures were approved by the Medical Ethical Com-
mittee of the Catharina Hospital, Eindhoven, The
Netherlands.
Study protocol. Two researchers (L.N.M.G. and A.T.S.)
were responsible for data collection and performed all
measurements. Patients and controls were interviewed
about general health, cardiovascular risk factors (smok-
ing), and comorbid conditions. Height and weight
allowed calculation of the body mass index. Leg length
was determined with a tape measure in standing posi-
tion and defined as the distance between the trochanter
major of the hip and the inferior aspect of the lateral
malleolus.21
After anthropometric measurements, participants
walked for 10 minutes on a treadmill to get accustomed
to its specifics.22 Intervals of rest, if necessary, were
allowed for IC patients. The preferred walking pace was
then determined, defined as “walk at a pace that is
comfortable and comparable to your outside walking.”22
The treadmill was started at 2.4 km/h. Speed was
increased in increments of 0.1 km/h until self-selected
comfortable walking speed was achieved. Speed was
increased in increments until the fastest pace was
attained and again decreased until the comfortable
speed was reached once more. Gait pattern measure-
ments were obtained at this final, self-selected comfort-
able walking pace. After 20 minutes of rest, IC patients
were questioned as to whether the pain had completely
resolved. If so, participants resumed treadmill walking.
During 1 minute of painless walking, gait parameters
were again obtained. Once IC patients experienced clau-
dication, pain was determined using a 4-point claudica-
tion pain scale (1, minimal discomfort; 2, moderate pain;
3, intense pain; 4, unbearable pain).23 Gait parameters
were obtained for 1 minute after pain moved from grade
2 to grade 3.
Fig 1. Study setup including the OptoGait system. The
transmitting (A) and receiving (B) bars are positioned on
both side bars of a treadmill. Spatiotemporal parameters
are obtained by interruptions in the LED signal when a
subject passes between the bars.
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Volume 66, Number 2Control subjects underwent the same measurements
just once (ie, pain-free trial). All participants walked bare-
foot on a flat treadmill to exclude differences based on
variable footwear.
Gait pattern. Spatial and temporal gaitparameterswere
collected using an OptoGait Photoelectric Cell System
(Microgate, Bolzano, Italy). This instrument consists of
two bars of 1 meter each, a transmitting and receiving
unit, respectively. Both bars contain 96 LED diodes, 1 cm
apart and 3 mm above floor level, that are positioned
onto the side bars of the treadmill (Fig 1). Parameters are
determined when LED diodes are interrupted by one of
two feet during walking. Data were sampled at a 1000 Hz
frequency and saved on a laptop (OptoGait version 1.9.9.0
software; Mircogate). The system is validated for spatio-
temporal gait parameters on a treadmill andwas found to
have a strong concurrent validity and test-retest reliability
as demonstrated in various populations including healthy
adults and patients after stroke or knee arthroplasty.24,25
Moreover, reported minimum detectable changes were
several times smaller than previously described differ-
ences in gait parameters of IC patients.
The following parameters were obtained: walking
speed; cadence; gait cycle duration; step length; step
time; duration of single and double limb support; swing
and stance phase duration; and contact, flat foot, and
propulsive phases (Fig 2). Step length was defined as
the distance from heel contact of the first foot to heel
contact of the subsequent contralateral foot.
Statistical analysis. Sample size calculation including
an a of .01 and a b of .80 was based on both a spatial
(stride length difference of 15 cm) and temporal
(percentage stance phase difference of 2%) outcome var-
iable and revealed a sample size of 25 and 14 subjects per
group, respectively, to realize a statistically significant
difference between both groups.11
Analyses and calculations of the data generated by the
OptoGait software were performed in a customized pro-
gram that was created in MATLAB R2012a (MathWorks,
Natick, Mass). Eighty representative steps were obtained
from each participant. Mean values and standard devia-
tions were calculated for individual parameters per leg.
In IC patients, the most symptomatic leg as based on the
patient’s history was considered the index leg. In healthy
controls, the index leg was randomly selected. SPSS 20.0
(IBM, Armonk, NY) was used for statistical analysis. Demo-
graphic characteristics were expressed as percentages or
group means and standard deviations. Differences be-
tween patients and controls were studied. In addition,
evaluation within the patient group was performed. The
symptomatic leg (eg, index leg) was compared with the
asymptomatic leg (eg, asymmetry), and the index leg
was compared during the pain-free and painful 1-minute
measuring period. Pearson c2 and Fisher exact tests wereused for analysis of categorical variables, whereas an inde-
pendent samples and paired t-tests analyzed continuous
variables. Variables that lacked normal distribution were
expressed as median and corresponding interquartile
ranges. Mann-Whitney U tests were used to compare
these variables. Pearson correlation coefficients (r) were
calculated to explore relations between spatiotemporal
parameters and clinical determinants (ie, walking speed
and ABI values). Statistical significance was set at P < .01
to control for multiple testing (type I error rate).RESULTS
Study populations. The study population consisted of
28 IC patients and 28 controls of similar age, gender dis-
tribution, height, weight, and leg length (Table I). The rate
of hypertension, however, was higher in the IC group.
ABIs of patients during rest and after treadmill walking
were 0.64 and 0.35, respectively. Almost half (n ¼ 13
[46%]) of the IC patients had unilateral complaints.
Gait characteristics of IC patients and controls. The IC
patients walked at a 1.2 km/h slower pace (IC patients,
3.3 km/h; controls, 4.5 km/h; P < .001; Table II), coinciding
with a 24% shorter step length (IC patients, 49.2 cm;
controls, 61.3 cm; P < .001), an 11% lower cadence (IC
patients, 111 steps/min; controls, 122 steps/min; P <.001),
and a 14% longer contact time (IC patients, 0.74 second;
controls, 0.65 second; P < .001).
Fig 2. Phases of the normal gait cycle. The gait cycle is divided into the stance phase and swing phase. The
stance phase, which is defined as the heel to toe contact of the foot, accounts for around 60% of the gait cycle;
the swing phase accounts for the remaining 40%. The stance phase can be divided into heel strike, the first
contact of the heel with the floor; foot flat phase, the period during which the complete foot is in contact with
the ground; and the propulsion phase, the termination of stance phase, which starts when the heel leaves the
ground and ends with complete set-off of the tip of the foot. (Adapted from Schafer RC. Clinical biomechanics.
Baltimore: Williams & Wilkins; 1987. Used with permission.)
Table I. Demographics of intermittent claudication (IC)
patients and controls undergoing gait analysis
Characteristic
IC patients
(n ¼ 28)
Controls
(n ¼ 28)
P
value
Gender, male 20 (71) 16 (57) .27
Age, years 68 (6.8) 68 (6.7) .75
Height, m 1.70 (0.08) 1.69 (0.08) .64
Weight, kg 80 (13) 75 (11) .10
Leg length, cm 80.6 (5.2) 80.5 (4.5) .92
Index leg, lefta 13 (46) 14 (50) .79
ABI of index leg
Rest 0.64 (0.19) 1.08 (0.16) <.001
After treadmill walking 0.35 (0.16) d
Duration of symptoms,
months
17 (16) d
Unilateral or bilateral
complaints, unilateral
13 (46) d
BMI, kg/m2 28.6 (4.9) 26.4 (4.7) .10
Smoking
Current smoker 14 (50) 3 (11) .02
Former smoker 11 (39) 14 (50)
Never smoker 3 (11) 11 (39)
Hypertension 19 (68) 6 (21) <.001
Diabetes mellitus 7 (25) 1 (4) .05
Cardiac diseaseb 8 (29) 2 (7) .08
Transient ischemic attack 2 (7) 1 (4) 1.00
COPD 4 (14) 3 (11) 1.00
Osteoarthritis 4 (14) 1 (4) .35
ABI, Ankle-brachial index; BMI, body mass index; COPD, chronic
obstructive pulmonary disease.
Categorical variables are presented as number (%). Continuous vari-
ables are presented as mean (standard deviation).
aThe index leg is the most symptomatic leg in IC patients and
randomly selected for controls.
bCardiac disease included coronary artery disease, arrhythmia, and
pacemaker.
518 Gommans et al Journal of Vascular Surgery
August 2017The relative duration of the single support phase was
also significantly shorter in IC patients compared with
controls (D2.3% and D3% for pain-free and painful ambu-
lation, respectively). Moreover, the relative duration of
the double support phase was significantly longer
(D4.3% and D5% for pain-free and painful ambulation,
respectively). IC patients also had an evidently longer
lasting foot flat phase (pain free, D4.9% [P ¼ .007] and
painful, D7.4% [P < .001]) and shorter propulsive phase
compared with controls (pain free, D4.1% [P ¼ .016]
and painful, D6.5% [P < .001]). Reported differences be-
tween IC patients and controls increased during painful
walking (Table II). Despite the difference in the relative
duration of the propulsive phase, no difference was
found in absolute propulsion time between IC patients
and controls.
Gait characteristics during pain-free and painful
walking in IC patients. Differences were found only in
the subphases of the stance phase when pain-free
walking and painful walking in IC patients were
compared. Once claudication pain was manifested, the
relative duration of flat foot increased significantly from
54.4% to 56.8% (P ¼ .002), whereas the relative contri-
bution of propulsion decreased from 34.0% to 31.6% (P <
.001). In addition, during painful walking, mean flat foot
time increased by 0.02 second (P < .001), whereas mean
propulsion time decreased by 0.02 second (P < .001).
No asymmetry in gait parameters was found when
comparing the index leg (ie, most symptomatic IC leg)
with the contralateral leg, for both the pain-free and
painful sessions (data not shown). A subanalysis of the
unilateral IC patients (n ¼ 13) also revealed no significant
differences between both legs of IC patients.
Correlations. No significant or clinically relevant correla-
tions were found between ABI values and any of the gait
parameters. For the analyses between walking speed
and gait parameters, two parameters were found to
correlate with walking speed. In healthy controls,walking speed was moderately correlated with relative
duration of the propulsion phase (r ¼ .541; P ¼ .005). In
contrast, no correlation was found for this variables in
Table II. Gait characteristics of intermittent claudication (IC) patients during painless and painful walking compared with
age-matched controls
Variable
IC patients (n ¼ 28)
P valuea Controls (n ¼ 28) P valueb P valuecPain free Painful
Walking speed, km/h 3.3 (0.6) 4.5 (0.8) <.001
Step length, cm 49.2 (8.4) 50.0 (8.7) .03 61.3 (9.8) <.001 <.001
Stride length, cm 99.6 (3.0) 99.9 (3.0) .62 123.6 (19.5) <.001 <.001
Cadence, steps/min 111 (7.9) 110 (8.0) .73 122 (9.6) <.001 <.001
Contact time, seconds 0.74 (0.06) 0.74 (0.07) .75 0.65 (0.1) <.001 <.001
Single support, % 32.4 (2.5) 31.7 (2.9) .01 34.7 (2.2) .001 <.001
Double support, % 35.3 (4.3) 36.0 (4.7) .03 31.0 (4.4) .001 <.001
Stance phase, % 67.7 (2.3) 67.6 (2.3) .88 65.7 (2.5) .003 .004
Swing phase, % 32.3 (2.3) 32.4 (2.3) .97 34.3 (2.5) .003 .003
Contact phase, % 11.6 (2.6) 11.6 (3.7) .88 12.4 (2.5) .227 .36
Contact phase, seconds 0.08 (0.02) 0.09 (0.03) .78 0.08 (0.02) .39 .42
Foot flat phase, % 54.4 (7.1) 56.8 (7.0) .002 49.5 (6.1) .007 <.001
Foot flat phase, seconds 0.40 (0.07) 0.42 (0.07) .001 0.32 (0.06) <.001 <.001
Propulsive phase, % 34.0 (6.5) 31.6 (5.9) <.001 38.1 (5.9) .02 <.001
Propulsive phase, seconds 0.25 (0.05) 0.23 (0.04) .001 0.25 (0.04) .81 .16
Step length: distance between heels of two subsequent feet. Stride length: distance between the first contact of the heel with the floor and the
second contact of the same heel. Contact time: time when the foot is in contact with the ground. Single support: time when only one foot touches the
ground. Double support: sum of two partial double supports of one gait cycle. Stance phase: similar to the contact time but expressed as percentage
of one gait cycle. Contact phase: moment between first contact of the heel (eg, heel strike) and foot flat. Foot flat: moment that the foot completely
touches the ground. Propulsive phase: moment from lifting the heel to complete set-off of the tip of the foot (Fig 2).
Data are presented as mean values (standard deviation).
aPaired t-test: pain free vs painful within group of IC patients.
bIndependent samples t-test: pain free vs control.
cIndependent samples t-test: painful vs control.
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Volume 66, Number 2IC patients (r ¼ .187; P ¼ .341). Foot flat time, on the other
hand, was significantly correlated to walking speed in
both IC patients and controls (Fig 3).
DISCUSSION
The purpose of this study was to explore spatiotem-
poral gait parameters in patients with IC during contin-
uous treadmill walking. This is the first study
investigating individual phases of the stance phase in
this population of patients using this approach. Patients
with IC walked 27% slower and were longer in stance
phase than healthy controls. In addition, distinct differ-
ences were present in the various different segments
of the stance phase. A 14% decrease in propulsion dura-
tion and a 17% increase in foot flat duration were
observed in IC patients. Interestingly, these alterations
were already present even before claudication pain
started.
Previous research reported contrasting findings of
altered gait pattern in patients with IC. Most studies
observed differences in percentage of stance phase
and double support, walking speed, and cadence that
are in line with our results.10,26,27 Others reported no ef-
fect of claudication on several temporal and spatial gait
measures.28,29 However, relatively small samples sizes
and suboptimal monitoring techniques, including theuse of papered walkways with stopwatch recording,
might explain the lack of differences in these studies,
as study populations were comparable with our IC pa-
tients in terms of age and ABIs.28,29
A unique aspect of this study is the assessment of gait
parameters during continuous treadmill walking. We
based our results on averaging data obtained during 80
steps, whereas others reported on just a couple of steps
during a short 4- to 7-meter walk.1,10 In the study of
McCully et al, patients walked on a treadmill until a suffi-
cient pain level was obtained, followed by gait measure-
ments during overground walking.30 Our treadmill-based
methodology also allowed capture of data immediately
after the pain threshold was reached, thereby excluding
confounding due to possible recovery processes. Based
on this optimized and standardized methodology, we
are confident that the results of this study truly reflect al-
terations in gait pattern that occur in patients with IC.
Determining differences in gait patterns between IC
patients and controls is deemed important for several
reasons. Walking is one of the most important daily activ-
ities of human life. From the very first step that is made,
individual gait patterns are optimized as walking is the
most economical means of locomotion. Gait speed is
known to be an independent predictor of all-cause mor-
tality, and gait speed differences between 0.36 km/h and
Fig 3. Scatterplot of the time for flat foot and walking speed. Intermittent claudication (IC) patients: r, 0.565
(P ¼ .002); controls: r, 0.784 (P < .001).
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speed differences in this study were at least twice as
large (1.2 km/h). Biomechanical gait alterations might
contribute to the slower walking speed of IC patients.
Further understanding and subsequent improvement
of the gait pattern might therefore contribute to the
prognosis of IC patients. The 14% difference in propulsion
between painful walking in IC patients and controls
revealed a Cohen d effect size of 0.48, which may be
interpreted as medium. So, even initiative small differ-
ences seem to have a substantial impact.
The precise explanation for these gait changes in IC is
still unknown. There may be a pathophysiologic mecha-
nism, related to the lower blood flow of IC patients, that
partly explains the gait changes observed in patients
with IC.33 This study showed that IC patients spend a
significantly longer percentage in flat foot position,
whereas no differences were found in absolute propul-
sion time. These findings are in line with a recent study
that also demonstrated no difference in relative calf
muscle activation.13 Hence, the additional time per gaitcycle as a consequence of the slower walking pace in
IC is completely used for the flat foot phase. This phe-
nomenon may reflect an intuitive adaptation because
skeletal muscle blood flow mainly occurs during the
relaxation phase of dynamic exercise. Moreover, the
relaxation period in part determines the magnitude of
arterial inflow.34 However, it might also be a strategy to
minimize oxygen use by a prolonged relaxation time.
Nevertheless, analogous to walking stops when claudica-
tion pain is maximized, IC patients have already “discon-
tinued” walking for a longer period during every step as a
means to allow sufficient blood inflow or to save use of
oxygen. This hypothesis may also explain why IC patients
take fewer rather than shorter steps when claudication
pain develops.26 In addition, altered gait parameters
might also be explained by the difference in walking
speed, as flat foot time correlated with walking speed
for both healthy controls and IC patients. Although gait
adaptations in response to ischemic pain cannot be
ruled out yet, the current research may fuel the search
for novel training modalities of SET aimed at improving
Journal of Vascular Surgery Gommans et al 521
Volume 66, Number 2gait pattern. Strategies to improve walking speed might
be a valuable starting point. Walking at a higher speed
during SET might increase training efficiency as patients
are thought to reach their claudication threshold earlier
by superseding the compensatory mechanism. On the
other hand, a higher walking speedmight also be advan-
tageous in terms of walking economy because IC pa-
tients are known to walk at a velocity below the
optimal point of energy costs.35 Future studies may focus
on the value of treadmill training on a higher pace. More-
over, efforts to increase calf muscle strength during SET
could also be vital to improve propulsion and eventually
the gait pattern of IC. This might be beneficial from the
perspective of the increased risk of falling as well. Last,
the value of rollover footwear (ie, MBT footwear) might
be of particular interest for IC patients as previous
research described reduced ankle plantar flexion mo-
ments during propulsion, without change in metabolic
costs or walking speed.36
Some study limitations need to be addressed. First, we
included only participants without additional comorbid-
ities (eg, osteoarthritis or previous lower limb surgery)
potentially affecting the gait pattern. Therefore, the pre-
sent findings were obtained from IC patients who were
in relatively good condition. As a consequence, the re-
sults might be overestimated in favor of a relatively
normal gait pattern. Conversely, results may not be
generalized to IC patients with numerous comorbid con-
ditions. Participants with diabetes mellitus were not
excluded, and one study reported lower ankle generative
mechanical work in patients with diabetes mellitus, even
in the absence of diabetic neuropathy. As diabetes mel-
litus was more prevalent among IC patients, propulsion is
possibly underestimated in the IC group. Second, we
captured data during treadmill walking, which is not
necessarily similar to overground walking, although Riley
et al reported identical kinematic and kinetic parame-
ters during treadmill and overground gait.37 It is thus
thought that movement analysis during treadmill
walking reveals valid results, all the more so when other
advantages of treadmill-based protocols are taken into
account. One might question the influence of a treadmill
protocol regarding the lack of asymmetry in spatiotem-
poral parameters, especially in unilateral IC patients, as
found in this study. However, Gardner et al also found
no asymmetry in IC patients during an overground
walking protocol.10 Third, this research included spatio-
temporal analyses only. As data on kinematics, kinetics,
and surface electromyography were not included, we
were not able to provide additional views from alterna-
tive perspectives. However, our findings might serve as
a starting point for further research to elucidate underly-
ing mechanisms of impaired walking function in pa-
tients with IC, for instance, the role of muscle strength
in gait alterations of IC.CONCLUSIONS
Patients with IC demonstrate altered spatiotemporal
gait parameters during treadmill walking that already
occur before the actual onset of claudication pain. This
gait pattern is characterized by a slower walking pace
and longer double support phase and stance phase.
The prolonged flat foot phase might be a possible
compensatory disease-related mechanism contributing
to this reduced walking speed.
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